Learn More
Invitrogen™ ALK Monoclonal Antibody (SP8)

Description
MA5-14528 targets ALK (Anaplastic Lymphoma Kinase) / p80 in IHC (P) and ICC/IF applications and shows reactivity with Human and Mouse samples. The MA5-14528 immunogen is recombinant protein corresponding to a region, which spans the tyrosine kinase catalytic domain and part of the C-terminus of the NPM-ALK transcript.
Specifications
Specifications
| Antigen | ALK |
| Applications | Immunohistochemistry (Paraffin), Immunocytochemistry |
| Classification | Monoclonal |
| Clone | SP8 |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Tissue culture supernatant, TBS with 1% BSA and 0.1% sodium azide; pH 7.5 |
| Gene | ALK |
| Gene Accession No. | P97793, Q9UM73 |
| Gene Alias | Alk; ALK tyrosine kinase receptor; ALK/NPM1 fusion gene; anaplastic lymphoma kinase; Anaplastic lymphoma kinase Ki1; Anaplastic Lymphoma Kinase p80; anaplastic lymphoma receptor tyrosine kinase; CD246; CD246 antigen; EC 2.7.10.1; kinase ALK; mutant anaplastic lymphoma kinase; NBLST3; npm-alk; p80; Tcrz; TFG/ALK |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.